Jan 7, 2025 · Domide is a synthetic glutamic acid derivative immunomodulator with anti-inflammatory, antiangiogenetic, sedative and hypnotic activity. In patients with erythema nodosum leprosum (ENL) the mechanism of action is not fully understood.

Jan 7, 2025 · Domide (ANTIGLAUCOMATOUS) is a carbonic anhydrase inhibitor that reduces elevated intraocular pressure in open-angle glaucoma or ocular hypertension. When used in combination with topic beta-adrenergic antagonists, dorzolamide has an additive effect of lowering intraocular pressure.

DOMIDE is a united kingdom trademark and brand of Actavis Group PTC ehf, Hafnarfirdi 220, ICELAND. This trademark was filed to UKIPO on Tuesday, May 26, 2009. The DOMIDE is under the trademark classification: Pharmaceutical Products; The DOMIDE trademark covers Pharmaceutical preparations and substances for the treatment of glaucoma.

Jun 22, 2022 · Domide 2% is a carbonic anhydrase inhibitor that reduces elevated intraocular pressure in open-angle glaucoma or ocular hypertension. When used in combination with topic beta-adrenergic antagonists, dorzolamide has an additive effect of lowering intraocular pressure.

Feb 26, 2025 · Mezigdomide is an oral CRBN-based molecular glue degrader targeting IKZF1/3, discovered by Celgene and currently being developed by Bristol Myers Squibb. Now in Ph. III trials for relapsed/refractory...

586 Followers, 293 Following, 9 Posts - See Instagram photos and videos from Domide (OFFICIAL) (@domide.id)

www.domide.com

爱企查为您提供DOMIDE2024年企业商标信息查询,包括企业商标注册信息、商标logo,商标类别等企业商标信息查询,让您更轻松的了解DOMIDE商标信息,查询更多关于DOMIDE商标信息就到爱企查官网！

772 Followers, 5,115 Following, 166 Posts - Olimpiu Domide (@domideolimpiu) on Instagram: ""

Mar 26, 2022 · Domide (ANTIGLAUCOMATOUS) is indicated: - as adjunctive therapy to beta-blockers, - as monotherapy in patients unresponsive to beta-blockers or in whom beta …